CompletedPhase 2

The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus

Egypt30 participantsStarted 2013-05

Plain-language summary

This study was initiated to evaluate the potential of dietary supplementation of omega-3 for providing an inexpensive, safe and effective therapeutic agent for managing atrophic/erosive lichen planus.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Clinical diagnosis of OLP (Presence of painful and atrophic-erosive oral Lesions, bilateral, mostly symmetrical lesions, presence of lace-like network of slightly raised white lines).
✓. Age between 30-60 years
✓. Ability to complete the present clinical trial.

Exclusion criteria

✕. Pregnant or breast feeding women (pregnancy test for women of child bearing age).
✕. Lichenoid reactions caused by certain drugs or dental amalgam.
✕. Therapy for oral lichen planus (OLP) in the 6 months prior to the study.
✕. Patient doesn't have hepatitis C \[after the patients' medical histories were recorded, the patients were given hepatic screening as published elsewhere. 2
✕. Presence of candidiasis before treatment.
✕. Patients with pre-existing diabetes or an initial random glucose level exceeding 200 mg/dL before initiating steroid therapy were excluded.
✕. Hypertensive patients
✕. Contraindications for corticosteroid use (immunodeficiency or severe heamatological alterations).

What they're measuring

Improve quality of the life (Oral Health Impact Profile)

Timeframe: 6 months

Trial details

NCT IDNCT02106468

SponsorOctober 6 University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-06

View on ClinicalTrials.gov More Oral Lichen Planus trials